ALTMAN, Michael D.,CASH, Brandon D.,CHILDERS, Matthew Lloyd,CUMMING, Jared N.,DEMONG, Duane E.,HAIDLE, Andrew Marc,HENDERSON, Timothy,JEWELL, James P.,LARSEN, Matthew A.,LIM, Jongwon,LU, Min,OTTE, Rya
申请号：
AU2019248545
公开号：
AU2019248545A1
申请日:
2019.04.01
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Compounds of general formula (I), of general formula (II), of general formula (III), of general formula (IV), of general formula (V), of general formula (VI), and their pharmaceutically acceptable salts, wherein all variables are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are compositions comprising such compounds, processes for the synthesis of such compounds, and to uses of such compounds, including administration of such compounds to induce immune response, to induce STING-dependent type I interferon production, and/or to treat a cell proliferation disorder, such as cancer.
